Pharmaceuticals Portfolio Pharmaceuticals Fund Annual Yield
FPHAX Fund | USD 27.16 0.16 0.59% |
Pharmaceuticals Portfolio Pharmaceuticals fundamentals help investors to digest information that contributes to Pharmaceuticals Portfolio's financial success or failures. It also enables traders to predict the movement of Pharmaceuticals Mutual Fund. The fundamental analysis module provides a way to measure Pharmaceuticals Portfolio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharmaceuticals Portfolio mutual fund.
Pharmaceuticals |
Pharmaceuticals Portfolio Pharmaceuticals Mutual Fund Annual Yield Analysis
Pharmaceuticals Portfolio's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Current Pharmaceuticals Portfolio Annual Yield | 0.01 % |
Most of Pharmaceuticals Portfolio's fundamental indicators, such as Annual Yield, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharmaceuticals Portfolio Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition |
In accordance with the recently published financial statements, Pharmaceuticals Portfolio Pharmaceuticals has an Annual Yield of 0.005%. This is 97.06% lower than that of the Fidelity Investments family and significantly higher than that of the Health category. The annual yield for all United States funds is 98.28% higher than that of the company.
Pharmaceuticals Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharmaceuticals Portfolio's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the mutual funds which would be a good addition to a portfolio. Peer analysis of Pharmaceuticals Portfolio could also be used in its relative valuation, which is a method of valuing Pharmaceuticals Portfolio by comparing valuation metrics of similar companies.Pharmaceuticals Portfolio is currently under evaluation in annual yield among similar funds.
Fund Asset Allocation for Pharmaceuticals Portfolio
The fund consists of 97.26% investments in stocks, with the rest of investments allocated between different money market instruments and various exotic instruments.Asset allocation divides Pharmaceuticals Portfolio's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Pharmaceuticals Fundamentals
Price To Earning | 18.56 X | |||
Price To Book | 2.04 X | |||
Price To Sales | 3.00 X | |||
Annual Yield | 0.01 % | |||
Year To Date Return | 13.97 % | |||
One Year Return | 23.43 % | |||
Three Year Return | 11.52 % | |||
Five Year Return | 14.67 % | |||
Ten Year Return | 14.79 % | |||
Net Asset | 863.31 M | |||
Last Dividend Paid | 0.05 | |||
Cash Position Weight | 1.85 % | |||
Equity Positions Weight | 97.26 % |
About Pharmaceuticals Portfolio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharmaceuticals Portfolio Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmaceuticals Portfolio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmaceuticals Portfolio Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Pharmaceuticals Portfolio Pharmaceuticals. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Pharmaceuticals Portfolio information on this page should be used as a complementary analysis to other Pharmaceuticals Portfolio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.